Please login to the form below

Not currently logged in
Email:
Password:

Antabio bolsters leadership team

The French biopharma appoints four new executives

Antibacterial treatment focused biopharma Antabio has appointed four new executives to strengthen its leadership team.

Gordon Waldron, the firm’s current chairman of the board, heads up Antabio’s finance department on a part time basis.

He joins the biopharma from finance and business development advice firm Sequoia Business Solutions, where he was chief executive officer.

Joining Waldron is Carole Sable, who will oversee Antabio’s clinical strategy.

Sable, has worked for numerous pharmaceutical companies including Vitae Pharmaceuticals, Revolution Medicines and Merck.

She said: “It is exciting to have the opportunity to work on the development of Antabio’s MBLi, which addresses a significant unmet need.”

Leading the firm’s business development dealings is Helmuth van Es, who joins the biopharma from biotech Galapagos, where he was founder.

Furthermore, David Lathbury, who was previously director of process chemistry at AstraZeneca and vice president of chemical development at AMRI, will manage all of Antabio’s CMC activities.

Marc Lemonnier, chief executive officer of Antabio, said: “We are thrilled to have attracted such high calibre talent and these new additions, along with expertise already in house, give Antabio the broad skill sets and high quality international leadership team needed as we embark on the next phase of our growth and move our antibacterial resistance pipeline towards the clinic.”

15th January 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics